S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NYSE:QGEN

QIAGEN Short Interest Ratio and Short Volume

$56.47
+1.91 (+3.50%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$56.37
$58.00
50-Day Range
$50.62
$56.47
52-Week Range
$45.58
$59.00
Volume
1.35 million shs
Average Volume
803,747 shs
Market Capitalization
$12.87 billion
P/E Ratio
22.06
Dividend Yield
N/A
Beta
0.24

QIAGEN (NYSE:QGEN) Short Interest Data

Current Short Volume
3,580,000 shares
Previous Short Volume
5,350,000 shares
Change Vs. Previous Month
-33.08%
Dollar Volume Sold Short
$191.17 million
Short Interest Ratio / Days to Cover
4.4
Last Record Date
November, 15 2021
Outstanding Shares
227,985,000 shares
Float Size
227,640,000 shares
Short Percent of Float
1.57%
Today's Trading Volume
1,348,179 shares
Average Trading Volume
803,747 shares
Today's Volume Vs. Average
67.74%
Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling QIAGEN ?

Sign up to receive the latest short interest report for QIAGEN and its competitors with MarketBeat's FREE newsletter.

QIAGEN (NYSE:QGEN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20213,580,000 shares $191.17 million -33.1%1.6%4.4 $53.40
10/29/20215,350,000 shares $298.32 million +3.1%2.4%7.7 $55.76
10/15/20215,190,000 shares $268.01 million +13.8%2.3%8 $51.64
9/30/20214,560,000 shares $235.66 million +18.4%2.0%5.8 $51.68
9/15/20213,850,000 shares $205.94 million +2.7%1.7%5.1 $53.49
8/31/20213,750,000 shares $209.33 million -6.0%1.7%5.1 $55.82
8/13/20213,990,000 shares $204.05 million -16.7%1.8%5.3 $51.14
7/30/20214,790,000 shares $252.86 million -5.5%2.1%6.3 $52.79
7/15/20215,070,000 shares $242.95 million +13.4%2.2%6.4 $47.92
6/30/20214,470,000 shares $216.26 million +4.0%2.0%6.1 $48.38
6/15/20214,300,000 shares $205.07 million -7.5%1.9%6.1 $47.69
5/28/20214,650,000 shares $229.52 million +5.7%2.0%6.4 $49.36
5/14/20214,400,000 shares $204.60 million -6.4%N/A6 $46.50
4/30/20214,700,000 shares $227.57 million +0.4%N/A5.3 $48.42
4/15/20214,680,000 shares $239.52 million +3.3%N/A5.5 $51.18
3/31/20214,530,000 shares $217.03 million -2.2%N/A5.2 $47.91
3/15/20214,630,000 shares $223.58 million +20.9%N/A5.4 $48.29
2/26/20213,830,000 shares $192.80 million -5.9%N/A4.1 $50.34
2/12/20214,070,000 shares $223.40 million +3.6%N/A4.4 $54.89
1/29/20213,930,000 shares $208.29 million -0.5%N/A4.3 $53.00
1/15/20213,950,000 shares $210.10 million -8.6%N/A4.7 $53.19
12/31/20204,320,000 shares $228.36 million -8.9%N/A4.8 $52.86
12/15/20204,740,000 shares $246.29 million -1.7%2.1%5.1 $51.96
11/30/20204,820,000 shares $233.72 million +5.9%2.1%5.6 $48.49
11/15/20204,550,000 shares $217.26 million +3.6%2.0%4.7 $47.75

Institutional Investors Shorting QIAGEN (NYSE:QGEN)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of QIAGEN. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
11/16/2021Jane Street Group LLCN/A41,400N/A$2.14 thousand
11/16/2021UBS Group AGN/A50,000N/A$2.58 thousand
11/16/2021Citadel Advisors LLC72,400135,300+86.9%$6.99 thousand
11/15/2021Pura Vida Investments LLC250,0000-100.0%$0.00
11/4/2021Harvest Management LLCN/A12,000N/A$620.00
11/4/2021Deutsche Bank AG38105+176.3%$5.00
10/12/2021Private Capital Management LLC16,4000-100.0%$0.00













QIAGEN (NYSE:QGEN) Short Interest Frequently Asked Questions

What is QIAGEN's current short interest?

Short interest is the volume of QIAGEN shares that have been sold short but have not yet been covered or closed out. As of November 15th, traders have sold 3,580,000 shares of QGEN short. 1.57% of QIAGEN's shares are currently sold short. Learn More on QIAGEN's current short interest.

What is a good short interest ratio for QIAGEN?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. QIAGEN currently has a short interest ratio of 4.0. Learn More on a good short interest ratio for QIAGEN

Which institutional investors are shorting QIAGEN?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of QIAGEN: Jane Street Group LLC, UBS Group AG, Citadel Advisors LLC, Pura Vida Investments LLC, Harvest Management LLC, Deutsche Bank AG, and Private Capital Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for QIAGEN?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.57% of QIAGEN's floating shares are currently sold short.

Is QIAGEN's short interest increasing or decreasing?

QIAGEN saw a drop in short interest during the month of November. As of November 15th, there was short interest totaling 3,580,000 shares, a drop of 33.1% from the previous total of 5,350,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is QIAGEN's float size?

QIAGEN currently has issued a total of 227,985,000 shares. Some of QIAGEN's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. QIAGEN currently has a public float of 227,640,000 shares.

How does QIAGEN's short interest compare to its competitors?

1.57% of QIAGEN's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to QIAGEN: Biogen Inc. (1.40%), Seagen Inc. (1.80%), Bio-Techne Co. (1.26%), Novozymes A/S (0.00%), Novavax, Inc. (0.00%), Repligen Co. (3.22%), argenx SE (1.96%), Neurocrine Biosciences, Inc. (3.43%), CRISPR Therapeutics AG (8.40%), and Denali Therapeutics Inc. (6.71%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($11.06 billion), S&P Global Inc. ($8.74 billion), Charter Communications, Inc. ($5.66 billion), Canadian Pacific Railway Limited ($5.43 billion), Wayfair Inc. ($4.23 billion), Palo Alto Networks, Inc. ($3.46 billion), DoorDash, Inc. ($3.41 billion), Teladoc Health, Inc. ($2.84 billion), Etsy, Inc. ($2.76 billion), and Zscaler, Inc. ($2.62 billion). View all of the most shorted stocks.

What does it mean to sell short QIAGEN stock?

Short selling QGEN is an investing strategy that aims to generate trading profit from QIAGEN as its price is falling. QIAGEN's stock is trading up $1.91 today. To short QIAGEN stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that QIAGEN will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against QIAGEN?

A short squeeze for QIAGEN occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of QGEN, which in turn drives the price of the stock up even further.

How often is QIAGEN's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including QGEN, twice per month. The most recent reporting period available is November, 15 2021.



This page was last updated on 11/27/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.